CRIC Labs

CRIC Labs is a specialized biotech venture studio based in Munich, Germany, dedicated to the creation and acceleration of innovative oncology companies. Founded by the late Dr. Axel Ullrich, a pioneer in targeted cancer therapy and co-founder of Sugen and Black Diamond Therapeutics, the studio leverages deep expertise in signal transduction and molecular biology. CRIC Labs identifies high-impact academic research and transforms it into robust drug discovery programs, primarily focusing on novel kinases and targeted protein degradation pathways. The organization provides a comprehensive ecosystem, including laboratory infrastructure, strategic management, and seed funding, to bridge the gap between basic research and clinical-stage development.